1Queiroz C, Barral-Netto M, Bacchi CE.Characterizing subopulations of neoplastic cells in serous effusions.The role of immunocytochem- istry[J].Acta Cytol,2001,45(1):18-22.
2Nathan N A,Narayan E,Smith M M. Cell block cytology.Improved preparation and its efficacy in diagnostic cytology[J].American Journal of Clinical Pathology,2000,(04):599-606.
3Mukhopadhyay S,Katzenstein A L. Comparison of monoclonal napsin A,polyclonal napsin A,and TTF-1 for determining lung origin in metastatic adenocarcinomas[J].American Journal of Clinical Pathology,2012,(05):703-711.
4Bishop J A,Sharma R,Illei P B. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung,breast,pancreas,colon,kidney,thyroid,and malignant mesothelioma[J].Human Pathology,2010,(01):20-25.
5Fatima N,Cohen C,Lawson D,Siddiqui M T. TTF-1 and Napsin A double stain:a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks[J].CANCER CYTOPATHOLOGY,2011,(02):127-133.
6Dejmek A,Naucler P,Smedjeback A. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions[J].DIAGNOSTIC CYTOPATHOLOGY,2007,(08):493-497.
7Turner B M,Cagle P T,Sainz M. Napsin A,a new marker for lung adenocarcinoma,is complementary and more sensitive and specific than thyroid transcription factor l in the differential diagnosis of primary pulmonary carcinoma:evaluation of 1674 cases by tissue microarray[J].ARCHIVES OF PATHOLOGY AND LABORATORY MEDICINE,2012,(02):163-171.
8Kaimaktchiev V,Terracciano L,Tornillo L. The homeobox intestinal differentiation factorCDX2 is selectively expressed in gastrointestinal adenocarcinomas[J].Modern Pathology,2004,(11):1392-1399.
9Chu P,Wu E,Weiss L M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms:a survey of 435 cases[J].Modern Pathology,2000,(09):962-972.
10Kende A I,Carr N J,Sobin L H. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract[J].HISTOPATHOLOGY,2003,(02):137-140.
